Trastuzumab Plus Chemotherapy vs Chemotherapy Alone in First-line HER2 Positive Advanced Biliary Tract Cancer Patients
מצבים רפואיים
Biliary Tract Cancer · HER2-positive Cancer · Advanced Cancer · Unresectable Biliary Tract Carcinoma · Metastatic Biliary Tract Carcinoma
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Homi Bhabha Cancer Hospital and Research Centre, Muzaffarpur, Muzaffarpur, Bihar, India
Tata Memorial Hospital, Mumbai, Maharashtra, India
PRABHAT BHARGAVA, DM (Sub-investigator)RITAM JOARDER, MD (Sub-investigator)MEHAK TRIKHA, MD (Sub-investigator)AKSHAY BAHETI, MD (Sub-investigator)RAJIV KAUSHAL, MD (Sub-investigator)SUBHASH YADAV, DNB (Sub-investigator)SHRADDHA PATKAR, Mch (Sub-investigator)MAHESH GOEL, MS (Sub-investigator)OMSHREE SHETTY, PhD (Sub-investigator)SUMAN ANKATHI, DNB (Sub-investigator)Institute of Medical Sciences & SUM Hospital, Bhubaneswar, Odisha, India
Homi Bhabha Cancer Hospital and Research Centre, Mūllānpur, Punjab, India
Contact: Principal Investigator (Pragyat Thakur)Mahamana Pandit Madan Mohan Malviya Cancer Centre (MPMMC) and Homi Bhabha Cancer Hospital (HBCH), Varanasi, Uttar Pradesh, India
MAX Super Speciality Hospital, SAKET, Delhi, India
מובילי המחקר
Vikas Ostwal, DM
Principal Investigator
Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India 400012